Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1301-1305, July 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Perez, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Perez, A. G.

Action of Hydroxyurea on the Nucleic Acid Metabolism and Viability of HeLa Cells1

J. H. Kim, A. S. Gelbard and A. G. Perez

Division of Biophysics, Sloan-Kettering Institute for Cancer Research, New York, New York 10021

Exposure of HeLa S-3 cells to 10-3 M hydroxyurea for a period of 16 hr produced a loss of cell viability accompanied by an inhibition of DNA synthesis. Continued synthesis of RNA and protein suggests an unbalanced growth similar to that previously observed with 5-fluorodeoxyuridine, excess thymidine, and 1-ß-D-arabinofuranosylcytosine. A threefold increase in thymidine kinase activity was observed as a result of unbalanced growth following the exposure of cells to hydroxyurea. When cells were exposed to 10-2 M hydroxyurea for short exposure times, however, appreciable loss of cell viability occurred only for those cells in the DNA synthetic phase.

1 This work was aided by grants from the National Cancer Institute (CA 08748) and the Atomic Energy Commission (AT (30-1)-910).

Received 12/29/66. Accepted 3/27/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.